Regression of Prostate Tumors Upon Combination of Hormone Ablation Therapy and Celecoxib in Vivo

Prostate - United States
doi 10.1002/pros.21297
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Wiley

Related search

Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence

Cancer Prevention Research
MedicineCancer ResearchOncology
2010English

Treatment of Hormone-Refractory Breast Cancer: Apoptosis and Regression of Human Tumors Implanted in Mice

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Retinoblastoma Regression Patterns Following Chemoreduction and Adjuvant Therapy in 557 Tumors

Archives of Ophthalmology
2009English

Mathematical Modeling of Prostate Cancer Progression in Response to Androgen Ablation Therapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

CD1d-Based Combination Therapy Eradicates Established Tumors in Mice

Journal of Immunology
AllergyImmunology
2009English

The Mechanisms and Managements of Hormone-Therapy Resistance in Breast and Prostate Cancers

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2005English

The Stress Hormone Norepinephrine Increases Migration of Prostate Cancer Cells in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2015English

Explaining Hormone-Deprivation Therapy Failure in Prostate Cancer Patients

Expert Review of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2009English

Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy